These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30148974)

  • 1. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature.
    Hirth J
    Hum Vaccin Immunother; 2019; 15(1):146-155. PubMed ID: 30148974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Goodman E; Reuschenbach M; Viering T; Luzak A; Greiner W; Hampl M; Jacob C
    Arch Gynecol Obstet; 2024 Nov; 310(5):2639-2646. PubMed ID: 39230793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population impact of HPV vaccines: summary of early evidence.
    Hariri S; Markowitz LE; Dunne EF; Unger ER
    J Adolesc Health; 2013 Dec; 53(6):679-82. PubMed ID: 24263069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM; Reynolds SM; Jacobson RM
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany.
    Kuznetsov AV; Müller RA; Ruzicka T; Herzinger T; Kuznetsov L
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1527-34. PubMed ID: 23216713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
    Moss JL; Reiter PL; Brewer NT
    Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview on the implementation of HPV vaccination in Europe.
    Bonanni P; Levi M; Latham NB; Bechini A; Tiscione E; Lai P; Panatto D; Gasparini R; Boccalini S
    Hum Vaccin; 2011; 7 Suppl():128-35. PubMed ID: 21245659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on barriers to adolescent human papillomavirus vaccination in the USA.
    Berenson AB
    Expert Rev Vaccines; 2015; 14(10):1377-84. PubMed ID: 26292763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
    Jeudin P; Liveright E; Del Carmen MG; Perkins RB
    Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the health burden of HPV infection through vaccination.
    Soper D
    Infect Dis Obstet Gynecol; 2006; 2006 Suppl():83084. PubMed ID: 16967913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.
    Kramer MR; Dunlop AL
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S102-10. PubMed ID: 22453332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C; Wouldes TA; Cameron LD; Elwood JM
    J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
    Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the monovalent to the nine-valent HPV vaccine.
    Pils S; Joura EA
    Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.